CRISPR/Cas9 Fusion to Dominant Negative 53BP1 Confers High Efficiency HDR-Based Genome Editing and Inhibits NHEJ Only at Cas9 Target Sites
MOLECULAR THERAPY(2019)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined